The FDA assessed the security and effectiveness of atidarsagene autotemcel according to knowledge from 37 kids who acquired atidarsagene autotemcel in two solitary-arm, open up-label medical trials As well as in an expanded obtain program.[7] Youngsters who acquired cure with atidarsagene autotemcel